The Corporate Accountability and Public Participation Africa (CAPPA) has alerted the Nigerian government against the use of Medicago COVID 19 vaccine (Covifenz) heavily funded by tobacco giant — Philip Morris, warning that the World Health Organisation (WHO) has refused to approve the vaccine.
It was gathered that WHO turned down approval of the Medicago vaccine because Philip Morris is a major shareholder in the Canadian based pharmaceutical company. Public health groups across the globe including in Canada support the WHO decision and have called on the Canadian government to find a suitable investor to replace Philip Morris in the company’s shareholding.
Medicago has equally signaled that it is seeking alternative investors and want the Canadian and Quebec governments to help facilitate such a transition. Unfortunately, the transition has not happened.
In a statement issued by CAPPA Director of Programmes, Philip Jakpor in Lagos, CAPPA said that as signatory to the WHO’s first public health treaty – the Framework Convention on Tobacco Control (WHO-FCTC) Nigeria should remain committed to its obligations including Article 5.3 which advised Parties to insulate their public health policy from the vested and commercial interests of the tobacco industry.
Guidelines for implementing this obligation make clear that “the tobacco industry should not be a partner in any initiative linked to setting or implementing public health policies, given that its interests are in direct conflict with the goals of public health.” Parties are directed that they “should not endorse, support, form partnerships with or participate in activities of the tobacco industry described as socially responsible.”
CAPPA Executive Director, Akinbode Oluwafemi said: “In as much as we appreciate the Canadian government for supplying COVID-19 Vaccines to Nigeria, we urge our government to be circumspect and ensure the product is not the Philip Morris funded Covifend. An industry that kills its customers and the rest of us who are exposed to tobacco via secondhand smoke cannot lead the way in solving either the tobacco menace or the coronavirus pandemic.”
Oluwafemi explained that Philip Morris is primarily a manufacturer of lethal products and continues to actively oppose smoking reduction measures across the globe including in Nigeria where its executives through well publicized articles promote heated tobacco products as a less harmful alternative to cigarettes despite overwhelming evidence to the contrary.
Through an initiative called the Conrad Nigeria Challenge, Philip Morris-funded Foundation for Smokefree World (FSFW) supports young people in the education sector who are subtly brainwashed into believing that the tobacco company is socially responsible and a stakeholder in public good.
“With at least nine other WHO-approved vaccines that are not tainted by tobacco companies’ funding in COVAX kitty, Nigeria is not obliged to accept vaccines tainted with industry funding. In fact, Nigeria can contact COVAX directly to obtain the approved products.”
Echoing the position of public health groups in Canada, Oluwafemi said rather than pose as a front for Philip Morris that the Canadian government should stand for public health by replacing Philip Morris shareholding in Medicago and stop partnerships that violate its FCTC Obligations.
“The control of one pandemic should not compromise another. COVID 19 vaccines or any other health product from companies with ties to the tobacco industry are not welcome in Nigeria. The acceptance of the Philip Morris vaccine and its use violates the FCTC Article 5.3.”, he insisted.
